One key factor is the rise in healthcare spending in emerging markets. The growing prevalence of chronic diseases, such as ...

The mean duration of intravenous therapy use was 8.81 days in continuous ... catheter insertion site (dorsal venous arch of hand, basilic vein, cephalic vein, forearm median vein, median elbow vein, ...

Dublin, March 20, 2025 (GLOBE NEWSWIRE) -- The "Intravenous (IV) Therapy and Vein Access Market" report has been added to ResearchAndMarkets.com's offering. The global market for IV therapy and ...

Utilizing the cephalic vein for venous access may facilitate rapid and less technically challenging intravenous catheter placement in patients under 12 weeks old. Establishing intravenous access is ...

basilic or cephalic veins of the arm at or near the axillary line. Thus, short peripheral intravenous catheters and PICCs were excluded from this pilot. However, a PICC placed at or trimmed to a ...

The global IV therapy and vein access devices market is on a trajectory of significant growth, projected to expand from USD 28.7 billion in 2024 to an estimated USD 47.3 billion by 2034. With a ...

DVT denotes deep-vein thrombosis, HIT heparin-induced thrombocytopenia, IVIG intravenous immune globulin ... unprovoked superficial-vein thrombosis (cephalic-vein thrombophlebitis) developed.

NEWARK, Del, June 26, 2024 (GLOBE NEWSWIRE) -- The IV therapy and vein access devices market is expected to reach USD 28.7 billion by 2024. From 2024 to 2034, revenue is expected to increase by 5. ...

Cephalic vein thrombosis is a blood clot in the cephalic vein in the arm. It occurs when something affects the vein’s blood flow to the heart. The condition generally resolves by itself but can ...

According to a report published by Future Market Insights, the IV treatment and vein access devices industry is anticipated to produce US$ 44.4 billion over the course of the projected year, with a ...